Breast Cancer Metastasis Suppressor 1 (BRMS1): Robust Biological and Pathological Data, But Still Enigmatic Mechanism of Action.

[1]  Zhuling Yang,et al.  BRMS1 and HPA as Progression, Clinical Biological Behaviors, and Poor Prognosis–related Biomarkers for Gallbladder Adenocarcinoma , 2016, Applied immunohistochemistry & molecular morphology : AIMM.

[2]  B. Sarcevic,et al.  Cyclin-dependent kinase-mediated phosphorylation of breast cancer metastasis suppressor 1 (BRMS1) affects cell migration , 2016, Cell cycle.

[3]  C. Park,et al.  Breast cancer metastasis suppressor 1 (BRMS1) attenuates TGF-β1-induced breast cancer cell aggressiveness through downregulating HIF-1α expression , 2015, BMC Cancer.

[4]  Jun Zhu,et al.  Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer , 2015, Oncotarget.

[5]  S. Souchelnytskyi,et al.  Breast carcinoma metastasis suppressor gene 1 (BRMS1): update on its role as the suppressor of cancer metastases , 2015, Cancer and Metastasis Reviews.

[6]  J. Massagué,et al.  Surviving at a Distance: Organ-Specific Metastasis. , 2015, Trends in cancer.

[7]  Pi-Xia Liang,et al.  Effect of BRMS1 expression on proliferation, migration and adhesion of mouse forestomach carcinoma. , 2015, Asian Pacific journal of tropical medicine.

[8]  M. Mezei,et al.  Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer , 2015, Molecular Cancer Therapeutics.

[9]  L. Bi,et al.  Quantitative Proteomics Analysis Reveals Novel Insights into Mechanisms of Action of Long Noncoding RNA Hox Transcript Antisense Intergenic RNA (HOTAIR) in HeLa Cells* , 2015, Molecular & Cellular Proteomics.

[10]  M. Zhang,et al.  Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer* , 2015, The Journal of Biological Chemistry.

[11]  Jian Dong,et al.  MRTF‐A and STAT3 promote MDA‐MB‐231 cell migration via hypermethylating BRSM1 , 2015, IUBMB life.

[12]  M. Hung,et al.  Expression of metastasis suppressor BRMS1 in breast cancer cells results in a marked delay in cellular adhesion to matrix , 2014, Molecular carcinogenesis.

[13]  David R. Jones,et al.  Loss of BRMS1 Promotes a Mesenchymal Phenotype through NF-κB-Dependent Regulation of Twist1 , 2014, Molecular and Cellular Biology.

[14]  Xinhua Lin,et al.  dBrms1 acts as a positive regulator of notch signaling in Drosophila wing. , 2014, Journal of genetics and genomics = Yi chuan xue bao.

[15]  D. Welch,et al.  Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell’s Journey , 2014, Cancer Microenvironment.

[16]  Junnian Zheng,et al.  BRMS1 Suppresses Glioma Progression by Regulating Invasion, Migration and Adhesion of Glioma Cells , 2014, PloS one.

[17]  Yibin Kang,et al.  A new Lnc in metastasis: long noncoding RNA mediates the prometastatic functions of TGF-β. , 2014, Cancer cell.

[18]  P. Meltzer,et al.  Toward a Drug Development Path That Targets Metastatic Progression in Osteosarcoma , 2014, Clinical Cancer Research.

[19]  David R. Jones,et al.  Inhibition of Breast Cancer Metastasis Suppressor 1 Promotes a Mesenchymal Phenotype in Lung Epithelial Cells That Express Oncogenic K-RasV12 and Loss of p53 , 2014, PloS one.

[20]  Zhenyu Zhu,et al.  Effect of BRMS1 on Tumorigenicity and Metastasis of Human Rectal Cancer , 2014, Cell Biochemistry and Biophysics.

[21]  D. Welch,et al.  Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer , 2014, British Journal of Cancer.

[22]  Carlos Quezada,et al.  Expression of the metastasis suppressor BRMS1 in uveal melanoma , 2014, Ecancermedicalscience.

[23]  P. Mehdipour,et al.  Genetics of breast cancer bone metastasis: a sequential multistep pattern , 2014, Clinical & Experimental Metastasis.

[24]  Cheryl D. Helgason,et al.  The non-coding transcriptome as a dynamic regulator of cancer metastasis , 2013, Cancer and Metastasis Reviews.

[25]  Wai Leong Tam,et al.  The epigenetics of epithelial-mesenchymal plasticity in cancer , 2013, Nature Medicine.

[26]  P. Bragado,et al.  TGFβ2 dictates disseminated tumour cell fate in target organs through TGFβ-RIII and p38α/β signalling , 2013, Nature Cell Biology.

[27]  Rama Kadamb,et al.  Sin3: insight into its transcription regulatory functions. , 2013, European journal of cell biology.

[28]  Vassilis Georgoulias,et al.  Breast Cancer Metastasis Suppressor-1 Promoter Methylation in Primary Breast Tumors and Corresponding Circulating Tumor Cells , 2013, Molecular Cancer Research.

[29]  D. Welch,et al.  The C-Terminal Putative Nuclear Localization Sequence of BReast cancer Metastasis Suppressor 1, BRMS1, Is Necessary for Metastasis Suppression , 2013, PloS one.

[30]  Ying Sun,et al.  Low BRMS1 expression promotes nasopharyngeal carcinoma metastasis in vitro and in vivo and is associated with poor patient survival , 2012, BMC Cancer.

[31]  H. Saiyin,et al.  Breast Cancer Metastasis Suppressor 1 Regulates Hepatocellular Carcinoma Cell Apoptosis via Suppressing Osteopontin Expression , 2012, PloS one.

[32]  S. Mehrotra,et al.  Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis , 2012, EMBO molecular medicine.

[33]  D. Hurst.  Metastasis suppression by BRMS1 associated with SIN3 chromatin remodeling complexes , 2012, Cancer and Metastasis Reviews.

[34]  V. A. Flørenes,et al.  Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival , 2012, BMC Cancer.

[35]  Da-Qiang Li,et al.  Metastasis-associated protein 1/nucleosome remodeling and histone deacetylase complex in cancer. , 2012, Cancer research.

[36]  R. Kesterson,et al.  Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis , 2012, Clinical & Experimental Metastasis.

[37]  Dong-mei Zhou,et al.  Loss of breast cancer metastasis suppressor 1 promotes ovarian cancer cell metastasis by increasing chemokine receptor 4 expression , 2011, Oncology reports.

[38]  C. Adra,et al.  Fascin Is a Key Regulator of Breast Cancer Invasion That Acts via the Modification of Metastasis-Associated Molecules , 2011, PloS one.

[39]  D. Welch,et al.  Unraveling the enigmatic complexities of BRMS1‐mediated metastasis suppression , 2011, FEBS letters.

[40]  S. Miyano,et al.  Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. , 2011, Cancer research.

[41]  Yibin Kang,et al.  Unravelling the complexity of metastasis — molecular understanding and targeted therapies , 2011, Nature Reviews Cancer.

[42]  G. Sotiropoulou,et al.  DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells. , 2011, Clinical chemistry.

[43]  Philip Smith,et al.  Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1 , 2011, Oncogene.

[44]  I. Fidler,et al.  The seed and soil hypothesis revisited—The role of tumor‐stroma interactions in metastasis to different organs , 2011, International journal of cancer.

[45]  J. Sleeman,et al.  Do all roads lead to Rome? Routes to metastasis development , 2011, International journal of cancer.

[46]  M. Esteller,et al.  Cancer epigenetics reaches mainstream oncology , 2011, Nature Medicine.

[47]  Yu-Chi Chen,et al.  Breast cancer metastasis to the bone: mechanisms of bone loss , 2010, Breast Cancer Research.

[48]  J. Bravo,et al.  Sorting nexin 6 interacts with breast cancer metastasis suppressor‐1 and promotes transcriptional repression , 2010, Journal of cellular biochemistry.

[49]  B. Sarcevic,et al.  Cyclin-dependent Kinase-mediated Phosphorylation of RBP1 and pRb Promotes Their Dissociation to Mediate Release of the SAP30·mSin3·HDAC Transcriptional Repressor Complex* , 2010, The Journal of Biological Chemistry.

[50]  Kedar S Vaidya,et al.  Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition. , 2010, Cancer research.

[51]  David Baltimore,et al.  Function of miR-146a in Controlling Treg Cell-Mediated Regulation of Th1 Responses , 2010, Cell.

[52]  A. Zelent,et al.  Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells , 2010, Proceedings of the National Academy of Sciences.

[53]  Alykhan S. Nagji,et al.  BRMS1 transcriptional repression correlates with CpG island methylation and advanced pathological stage in non‐small cell lung cancer , 2010, The Journal of pathology.

[54]  H. Ford,et al.  Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression , 2010, Journal of Mammary Gland Biology and Neoplasia.

[55]  Howard Y. Chang,et al.  Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis , 2010, Nature.

[56]  J. Workman,et al.  Deacetylase inhibitors dissociate the histone-targeting ING2 subunit from the Sin3 complex. , 2010, Chemistry & biology.

[57]  F. Yu,et al.  Tumor Invasion and Metastasis Initiated by mir-106b in Breast Cancer by Targeting BRMS1 and RB. , 2009 .

[58]  D. Welch,et al.  Metastamir: the field of metastasis-regulatory microRNA is spreading. , 2009, Cancer research.

[59]  D. Welch,et al.  Linking metastasis suppression with metastamiR regulation , 2009, Cell cycle.

[60]  N. Crawford,et al.  The Metastasis Efficiency Modifier Ribosomal RNA Processing 1 Homolog B (RRP1B) Is a Chromatin-associated Factor* , 2009, The Journal of Biological Chemistry.

[61]  Luyang Sun,et al.  LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast Cancer , 2009, Cell.

[62]  Martin R. Johnson,et al.  A Shift from Nuclear to Cytoplasmic Breast Cancer Metastasis Suppressor 1 Expression Is Associated with Highly Proliferative Estrogen Receptor-Negative Breast Cancers , 2009, Tumor Biology.

[63]  K. Hunter,et al.  Preclinical Drug Development Must Consider the Impact on Metastasis , 2009, Clinical Cancer Research.

[64]  R. Urrutia,et al.  Sin3: master scaffold and transcriptional corepressor. , 2009, Biochimica et biophysica acta.

[65]  Philip Smith,et al.  Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in non-small cell lung cancer. , 2009, Cancer letters.

[66]  Kedar S Vaidya,et al.  Over-expression of the BRMS1 family member SUDS3 does not suppress metastasis of human cancer cells. , 2009, Cancer letters.

[67]  Paula D. Bos,et al.  Metastasis: from dissemination to organ-specific colonization , 2009, Nature Reviews Cancer.

[68]  Kedar S Vaidya,et al.  Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. , 2009, Cancer research.

[69]  G. Casey,et al.  BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-κB binding site of the uPA promoter , 2009, Clinical & Experimental Metastasis.

[70]  Kedar S Vaidya,et al.  Breast Cancer Metastasis Suppressor-1 Differentially Modulates Growth Factor Signaling* , 2008, Journal of Biological Chemistry.

[71]  Xiaoqi Liu,et al.  Breast cancer metastasis suppressor 1 inhibits SDF-1alpha-induced migration of non-small cell lung cancer by decreasing CXCR4 expression. , 2008, Cancer letters.

[72]  G. Casey,et al.  Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1 , 2008, International journal of cancer.

[73]  D. Welch,et al.  Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer , 2008, Clinical & Experimental Metastasis.

[74]  Kedar S Vaidya,et al.  BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiation , 2008, Clinical & Experimental Metastasis.

[75]  Kedar S Vaidya,et al.  Alterations of BRMS1-ARID4A Interaction Modify Gene Expression but Still Suppress Metastasis in Human Breast Cancer Cells* , 2008, Journal of Biological Chemistry.

[76]  Fu-cai Li,et al.  [Expression and clinical significance of breast cancer metastasis suppressor 1 mRNA in supraglottic laryngeal carcinoma]. , 2008, Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery.

[77]  Kedar S Vaidya,et al.  BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process. , 2008, The American journal of pathology.

[78]  Jinghui Zhang,et al.  Rrp1b, a New Candidate Susceptibility Gene for Breast Cancer Progression and Metastasis , 2007, PLoS genetics.

[79]  B. Weimer,et al.  Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppression , 2007, Clinical & Experimental Metastasis.

[80]  J. Bravo,et al.  Proteomics-based strategy to delineate the molecular mechanisms of the metastasis suppressor gene BRMS1. , 2007, Journal of proteome research.

[81]  I. Fidler,et al.  The role of the organ microenvironment in the biology and therapy of cancer metastasis , 2007, Journal of cellular biochemistry.

[82]  Jie Jiang,et al.  [Inhibitory effect of breast cancer metastasis suppressor l gene on metastasis of human ovarian cancer cell in vitro and in vivo]. , 2007, Zhonghua fu chan ke za zhi.

[83]  S. Eccles,et al.  Metastasis: recent discoveries and novel treatment strategies , 2007, The Lancet.

[84]  G. Bevilacqua,et al.  High level of messenger RNA for BRMS1 in primary breast carcinomas is associated with poor prognosis , 2007, International journal of cancer.

[85]  G. Casey,et al.  Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-κB activation , 2007, Molecular Cancer.

[86]  M. Oursler,et al.  Breast cancer bone metastasis and current small therapeutics , 2007, Cancer and Metastasis Reviews.

[87]  T. Choueiri,et al.  Loss of Breast Cancer Metastasis Suppressor 1 Protein Expression Predicts Reduced Disease-Free Survival in Subsets of Breast Cancer Patients , 2006, Clinical Cancer Research.

[88]  T. Toyama,et al.  Reduced Expression of the Breast Cancer Metastasis Suppressor 1 mRNA Is Correlated with Poor Progress in Breast Cancer , 2006, Clinical Cancer Research.

[89]  D. Welch,et al.  Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone. , 2006, Biochemical and biophysical research communications.

[90]  Philip Smith,et al.  Breast Cancer Metastasis Suppressor 1 Functions as a Corepressor by Enhancing Histone Deacetylase 1-Mediated Deacetylation of RelA/p65 and Promoting Apoptosis , 2006, Molecular and Cellular Biology.

[91]  H. Stunnenberg,et al.  Molecular characterization of Sin3 PAH-domain interactor specificity and identification of PAH partners , 2006, Nucleic acids research.

[92]  N. Yang,et al.  Integrative genomic analysis of protein kinase C (PKC) family identifies PKCiota as a biomarker and potential oncogene in ovarian carcinoma. , 2006, Cancer research.

[93]  D. Welch,et al.  Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1). , 2006, Cancer letters.

[94]  Song Tan,et al.  ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation. , 2006, Molecular cell.

[95]  W. Di,et al.  Suppression of human ovarian carcinoma metastasis by the metastasis‐suppressor gene, BRMS1 , 2005, International Journal of Gynecologic Cancer.

[96]  M. Duffy,et al.  Expression of the Breast Cancer Metastasis Suppressor Gene, BRMS1, in Human Breast Carcinoma: Lack of Correlation with Metastasis to Axillary Lymph Nodes , 2005, Tumor Biology.

[97]  G. Casey,et al.  Breast Cancer Metastasis Suppressor 1 Inhibits Gene Expression by Targeting Nuclear Factor-κB Activity , 2005 .

[98]  K. Pacak,et al.  Downregulation of metastasis suppressor genes in malignant pheochromocytoma , 2005, International journal of cancer.

[99]  Joseph C. Shope,et al.  Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells. , 2005, Cancer research.

[100]  W. Gerald,et al.  Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. , 2005, The Journal of clinical investigation.

[101]  J. Qin,et al.  Identification of a novel BRMS1-homologue protein p40 as a component of the mSin3A/p33(ING1b)/HDAC1 deacetylase complex. , 2004, Biochemical and biophysical research communications.

[102]  D. Welch,et al.  Breast cancer metastatic potential: Correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells , 2004, International journal of cancer.

[103]  J. Workman,et al.  Breast Cancer Metastasis Suppressor 1 (BRMS1) Forms Complexes with Retinoblastoma-binding Protein 1 (RBP1) and the mSin3 Histone Deacetylase Complex and Represses Transcription* , 2004, Journal of Biological Chemistry.

[104]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[105]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[106]  Michael Karin,et al.  NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.

[107]  A. Alessandrini,et al.  Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1. , 2002, Experimental cell research.

[108]  D. Welch,et al.  Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. , 2001, Cancer research.

[109]  D. Welch,et al.  Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. , 2000, Cancer research.

[110]  Weidong Wang,et al.  NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. , 1998, Molecular cell.

[111]  D. Welch,et al.  Genetic and epigenetic regulation of human breast cancer progression and metastasis , 1998 .

[112]  B. Weissman,et al.  Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11. , 1996, Cancer research.

[113]  J. Gudmundsson,et al.  Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations. , 1995, British Journal of Cancer.

[114]  G. Hampton,et al.  Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3. , 1995, Cancer research.

[115]  G. Hampton,et al.  Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3. , 1994, Cancer research.

[116]  P. Devilee,et al.  Differences in patterns of allelic loss between two common types of adult cancer, breast and colon carcinoma, and Wilms' tumor of childhood , 1991, International journal of cancer.

[117]  H. Ding,et al.  BRMS1 Regulates Apoptosis in Non-small Cell Lung Cancer Cells , 2014, Cell Biochemistry and Biophysics.

[118]  D. Welch,et al.  Metastasis suppressors in breast cancers: mechanistic insights and clinical potential , 2013, Journal of Molecular Medicine.

[119]  D. Spector,et al.  Molecular and Cellular Pathobiology The Noncoding RNA MALAT 1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells , 2013 .

[120]  D. Welch,et al.  Metastasis suppressor genes at the interface between the environment and tumor cell growth. , 2011, International review of cell and molecular biology.

[121]  P. McDonel,et al.  Keeping things quiet: roles of NuRD and Sin3 co-repressor complexes during mammalian development. , 2009, The international journal of biochemistry & cell biology.

[122]  D. Welch,et al.  Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model , 2008, Clinical & Experimental Metastasis.

[123]  G. Casey,et al.  Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells , 2004, Clinical & Experimental Metastasis.

[124]  Karl Ekwall,et al.  Sin3: a flexible regulator of global gene expression and genome stability , 2004, Current Genetics.

[125]  N. Christensen,et al.  Analysis of mechanisms underlying BRMS1 suppression of metastasis , 2004, Clinical & Experimental Metastasis.

[126]  D. Theodorescu,et al.  The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines , 2004, Clinical & Experimental Metastasis.

[127]  Identification and Characterization of SAP25, a Novel Component of the mSin3 Corepressor Complex , 2022 .